Keywords: China Biologic, 2009 results, Zacks buy rating

China Biologic Products given a “strong buy” ranking by Zacks, after record fourth-quarter results

Article | 14 April 2010

China Biologic Products, a plasma-based biopharmaceutical company which recently reported record revenue for the fourth quarter and 2009, is cheap, trading ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

China Biologic

Go to company listing